Complete Genome Sequence of Serratia marcescens SmUNAM836, a Nonpigmented Multidrug-Resistant Strain Isolated from a Mexican Patient with Obstructive Pulmonary Disease

Genome Announcements
Luisa Sandner-MirandaRosario Morales-Espinosa

Abstract

Serratia marcescens SmUNAM836 is a multidrug-resistant clinical strain isolated in Mexico City from a patient with chronic obstructive pulmonary disease. Its complete genome sequence was determined using PacBio RS II SMRT technology, consisting of a 5.2-Mb chromosome and a 26.3-kb plasmid, encoding multiple resistance determinants and virulence factors.

References

Dec 17, 2009·BMC Bioinformatics·Christiam CamachoThomas L Madden
Mar 15, 2011·Current Protocols in Bioinformatics·Todd J TreangenMihai Pop
Jun 16, 2011·Nucleic Acids Research·You ZhouDavid S Wishart
Jul 12, 2012·The Journal of Antimicrobial Chemotherapy·Ea ZankariMette Voldby Larsen
May 7, 2013·Nature Methods·Chen-Shan ChinJonas Korlach
May 8, 2013·Antimicrobial Agents and Chemotherapy·Andrew G McArthurGerard D Wright
Mar 20, 2014·Bioinformatics·Torsten Seemann
Jul 30, 2014·Genome Biology and Evolution·Atsushi IguchiTetsuya Hayashi
Apr 29, 2015·Nucleic Acids Research·Bhavjinder K DhillonFiona S L Brinkman

❮ Previous
Next ❯

Datasets Mentioned

BETA
CP012685
CP012686

Methods Mentioned

BETA
phosphotransferase

Software Mentioned

SMRT portal
IslandViewer3
Quiver
blastp
ResFinder
Prokka
PHAST
Minimus2
VirulenceFinder

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

CRISPR Ribonucleases Deactivation

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on mechanisms that underlie deactivation of CRISPR ribonucleases. Here is the latest research.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

CRISPRi Screens for Antibiotics

The CRISPR-Cas system is a gene editing technique that can be used for high-throughput genome-wide screens to identify modes of actions of novel antibiotics. Here is the latest research.